Home
Browse
Search
Latest additions
Policies
FAQ
About Open Access
Browse by Author
Browse by Year
Browsing publications by
Dr Stuart McCracken
Newcastle Authors
Title
Year
Dr Stuart McCracken
Dr Kanagasabai Sahadevan
Professor Hing Leung
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis
2012
Dr Stuart McCracken
ERK5 signalling in prostate cancer promotes an invasive phenotype
2011
Dr Luke Gaughan
Dr Stuart McCracken
Professor Craig Robson
Dr Steven Powell
FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth
2011
Dr Luke Gaughan
Dr Jacqueline Stockley
Nan Wang
Dr Stuart McCracken
Dr Kelly Coffey
et al.
Regulation of the androgen receptor by SET9-mediated methylation
2011
Dr Stuart McCracken
Garrett Durkan
Professor Robert Pickard
Professor Craig Robson
Diagnosis and management of prostate cancer in the older man
2010
Professor Hing Leung
Dr Arthur Mckie
Dr Stuart McCracken
Dr Helen Maitland
Dr Sharon Olijslagers
et al.
Loss of Sprouty2 Drives an Invasive Phenotype in Prostate Cancer and May Co-operate with HER2/3 in a Subgroup with Aggressive Disease
2009
Dr Stuart McCracken
Dr Rakesh Heer
Dr Marie Mathers
Benjamin Jenkins
Professor Craig Robson
et al.
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer
2008
Dr Stuart McCracken
Professor David Neal
Professor Hing Leung
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer
2007
Dr Ian Logan
Dr Luke Gaughan
Dr Stuart McCracken
Dr Vasileia Sapountzi
Professor Hing Leung
et al.
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer
2006
Bharat Gowardhan
David Douglas
Dr Marie Mathers
Dr Arthur Mckie
Dr Stuart McCracken
et al.
Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer
2005
1
2
